Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vortioxetine for Menopausal Depression and Associated Symptoms

NCT02234362 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02234362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02234362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vortioxetine for Menopausal Depression and Associated Symptoms
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 12, 2015
Completion date
September 29, 2016
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, hot flashes, menopause, sleep, vasomotor disturbance